Kanabolytix is the cannabis testing division of the Toxikon Corporation. Kanabolytix draws on Toxikon’s longstanding history and depth of experience in analytical sciences to offer consumers and producers confidence in the safety and efficacy of commercial cannabis products. Toxikon, founded in 1982, is a preclinical contract research organization (CRO) that provides in vitro, in vivo, and analytical testing services for the pharmaceutical, biotechnology, and medical device sectors. Toxikon is accredited to ISO/IEC 17025, and is registered with the United States Food and Drug Administration and the Japan Ministry of Health, Labor, and Welfare for drug and medical testing.
For Technical Support with this webpage, please contact support. For all other questions, please contact email@example.com or 201.580.2050